Page 313 - 73_04

VOL. 73 (4), 1093-1125, 2007 PAPEL DE LA CAVEOLINA-1 EN LA...

(94) RAJJAYABUN, P. H., GARG, S., DURKAN, G. C., CHARLTON, R., ROBINSON, M. C. AND
(95) MELLON, J. K. (2001) Caveolin-1 expression is associated with high-grade
bladder cancer. Urology. 58: 811-814.
(96) TIRADO, O. M., MATEO-LOZANO, S., VILLAR, J., DETTIN, L. E., LLORT, A., GALLEGO,
S., BAN, J., KOVAR, H. AND NOTARIO, V. (2006) Caveolin-1 (CAV1) is a target
(97) of EWS/FLI-1 and a key determinant of the oncogenic phenotype and tumo-
rigenicity of Ewing’s sarcoma cells. Cancer Res. 66: 9937-9947.
(98) WILLIAMS, T. M., HASSAN, G. S., LI, J., COHEN, A. W., MEDINA, F., FRANK, P. G.,
(99) PESTELL, R. G., DI VIZIO, D., LODA, M. AND LISANTI, M. P. (2005) Caveolin-1
(100) promotes tumor progression in an autochthonous mouse model of prostate
cancer: genetic ablation of Cav-1 delays advanced prostate tumor develop-
(101) ment in tramp mice. J. Biol. Chem. 280: 25134-25145.
(102) SALATINO, M., BEGUELIN, W., PETERS, M. G., CARNEVALE, R., PROIETTI, C. J.,
(103) GALIGNIANA, M. D., VEDOY, C. G., SCHILLACI, R., CHARREAU, E. H., SOGAYAR, M.
(104) C. AND ELIZALDE, P. V. (2006) Progestin-induced caveolin-1 expression me-
(105) diates breast cancer cell proliferation. Oncogene. 25: 7723-7739.
(106) YANG, G., TIMME, T. L., FROLOV, A., WHEELER, T. M. AND THOMPSON, T. C.
(2005) Combined c-Myc and caveolin-1 expression in human prostate car-
(107) cinoma predicts prostate carcinoma progression. Cancer. 103: 1186-1194.
RAZANI, B. AND LISANTI, M. P. (2001) Caveolin-deficient mice: insights into
caveolar function human disease. J. Clin. Invest. 108: 1553-1561.
WILLIAMS, T. M., CHEUNG, M. W., PARK, D. S., RAZANI, B., COHEN, A. W., MU-
LLER, W. J., DI VIZIO, D., CHOPRA, N. G., PESTELL, R. G. AND LISANTI, M. P.
(2003) Loss of caveolin-1 gene expression accelerates the development of
dysplastic mammary lesions in tumor-prone transgenic mice. Mol. Biol.
Cell. 14. 1027-1042.
GLENNEY, J. R., JR. (1992) The sequence of human caveolin reveals identity
with VIP21, a component of transport vesicles. FEBS Lett. 314: 45-48.
HENLEY, J. R., KRUEGER, E. W., OSWALD, B. J. AND MCNIVEN, M. A. (1998)
Dynamin-mediated internalization of caveolae. J. Cell. Biol. 141: 85–99.
MALABA, L., SMELAND, S., SENOO, H., NORUM, K. R., BERG, T., BLOMHOFF, R. AND
KINDBERG, G. M. (1995) Retinol-binding protein and asialo-orosomucoid are
taken up by different pathways in liver cells. J. Biol. Chem. 15686-15692.
JANICOT, M., FOUQUE, F. AND DESBUQUOIS, B. (1991) Activation of rat liver
adenylate cyclase by cholera toxin requires toxin internalization and pro-
cessing in endosomes. J. Biol. Chem. 266: 12858-12865.
MONTESANO, R., ROTH, J., ROBERT, A. AND ORCI, L. (1982) Non-coated membra-
ne invaginations are involved in binding and internalization of cholera and
tetanus toxins. Nature (Lond). 296: 651–653.
JANICOT, M., CLOT, J. P. AND DESBUQUOIS, B. (1988) Interactions of cholera
toxin with isolated hepatocytes. Effects of low pH, chloroquine and monen-
sin on toxin internalization, processing and action. Biochem. J. 253: 735-
743.
OH, P., MCINTOSH, D. P. AND SCHNITZER, J. E. (1998) Dynamin at the neck of
caveolae mediates their budding to form transport vesicles by GTP-driven

1123